Former Chairman of the University of Virginia Department of Surgery will become a key member of UA Senior Vice President for Health Sciences Dr. Michael Dake’s fast-growing Leadership Team.
Dr. Galgiani, director of the University of Arizona Valley Fever Center for Excellence, will present “Valley Fever (Coccidioidomycosis): In Arizona and Beyond” at the conference, which will be held in Scottsdale, July 26–29. Mills is a Valley fever survivor.
UA College of Medicine – Phoenix scientists cross-utilize plant biology, medicine and engineering to create novel platform.
The five-year National Institutes of Health grant will enable Charles Downs, PhD, to study whether the non-pharmacological supplement curcumin can prevent lung injury.
As part of the National Institutes of Health’s “NIH in Your State” social media campaign about NIH investment in fiscal year 2017 and the impact of federally funded research on citizens’ health, the NIH recently tweeted that Arizona received $189 million in research support in FY2017. The University of Arizona Health Sciences received $70.3 million in NIH funding during FY2017, conducting research addressing statewide and global health challenges.
Rachna Shroff, MD, led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations.
Data from patient-ordered tests show a second seasonal surge, says Dr. John Galgiani, a UA professor and director the UA Valley Fever Center for Excellence. This gets ahead of state statistics in a year when big numbers already were predicted and are being borne out.
Medical students at the University of Arizona College of Medicine – Tucson will help host a free health clinic in the border city.
The article highlights the success of the event that connects hospitals, clinics and other health-care organizations with the physicians, nurses and other health professionals who are available to help meet the organizations' telehealth needs. Attendees gave SPS 2017 rave reviews.
Join us as we wish Melanie the best on Monday, June 18: 3:30 - 5:00 pm, Room 2920, UACC.
Some people who take statins to lower cholesterol have a slightly higher risk of developing type-2 diabetes. Genetic epidemiologist Yann Klimentidis, PhD, at the UA Mel and Enid Zuckerman College of Public Health received a $1.1 million grant from the National Institutes of Health to study the connection between type-2 diabetes and cardiovascular disease.
Joint statement empowers parents, young adults and physicians to increase vaccination rates and screenings to eliminate HPV-related cancers, starting with cervical cancer.
Melissa Herbst-Kralovetz of the University of Arizona Cancer Center and UA College of Medicine – Phoenix has found a direct relationship between “good” bacteria and cervical health and “bad” bacteria and increased cancer risk.
ArizonaMed, the college's current curriculum delivery system, will be retired.
The four-year National Cancer Institute grant will enable Terry A. Badger, PhD, RN, PMHCNS-BC, FAAN, to study whether psychosocial interventions will help ethnically diverse survivors improve their symptoms.
The University of Arizona’s Center for Integrative Medicine (UA CIM) is giving residents and fellows at home and across the country the education and support needed to minimize stress and burnout.
Deploying an interdisciplinary, team-based outreach model for delivery of care, the University of Arizona Health Sciences’ “Project Taking Charge” works to improve health in Tucson’s most underserved communities through patient self-management.
The mentorship-based, highly competitive programs work to recruit and ultimately graduate a more diverse student body dedicated to serving Arizona and the nation’s most at-risk and underserved populations.
The study found poor sleep quality was associated with nighttime snacking and a high likelihood of craving junk food. The study also found that junk food cravings were associated with increased risk of obesity, diabetes and other health problems.
The University of Arizona has licensed inventions created by two College of Medicine – Tucson appointees to the startup MCR Therapeutics, which develops therapeutics for skin cancer and the treatment of pigment disorders.